Comparison of clinical effects of two latanoprost 0.005% solutions (Xalatan® and Arulatan®) in primary open-angle glaucoma or ocular hypertensive patients: a randomized clinical trial
2018 ◽
Vol 7
(1)
◽
pp. 145-156
◽
2005 ◽
Vol 89
(5)
◽
pp. 547-549
◽
Keyword(s):
Keyword(s):